Pet Pharm Biotech Dividends and Buybacks
Dividend criteria checks 0/6
Pet Pharm Biotech is a dividend paying company with a current yield of 0.47%.
Key information
0.5%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
No updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 7762's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 7762's dividend payments have been increasing.
Dividend Yield vs Market
| Pet Pharm Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (7762) | 0.5% |
| Market Bottom 25% (TW) | 1.8% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Biotechs) | 2.5% |
| Analyst forecast (7762) (up to 3 years) | n/a |
Notable Dividend: 7762's dividend (0.47%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.75%).
High Dividend: 7762's dividend (0.47%) is low compared to the top 25% of dividend payers in the TW market (4.5%).
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 7762's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 7762 has not reported any payouts.